Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin

Internal Medicine Journal

Volumn 44, Issue 7, 2014, Pages 690-693

  Page, S R ^a   Yee, K C ^b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Clarithromycin; Drug interaction; Rhabdomyolysis; Simvastatin; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; CLARITHROMYCIN; CREATINE KINASE; EZETIMIBE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; GAMMA GLUTAMYLTRANSFERASE; GLYCERYL TRINITRATE; METOPROLOL; MYOGLOBIN; POTASSIUM; PROPYLTHIOURACIL; RAMIPRIL; SALBUTAMOL; SIMVASTATIN; TIOTROPIUM BROMIDE; TROPONIN T; UREA; CYTOCHROME P450 3A INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANKLE EDEMA; ARTICLE; ASTHMA; CASE REPORT; CAUCASIAN; CHEST INFECTION; CREATINE KINASE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LIMB WEAKNESS; MUSCLE STRENGTH; MYALGIA; MYOPATHY; PHYSIOTHERAPY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RECURRENT INFECTION; RHABDOMYOLYSIS; UREA BLOOD LEVEL; VERY ELDERLY; WHEEZING; CHEMICALLY INDUCED; DRUG INTERACTION; PHYSIOLOGY;

AGED, 80 AND OVER; CLARITHROMYCIN; CYTOCHROME P-450 CYP3A INHIBITORS; DRUG INTERACTIONS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 84903826586     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12464     Document Type: Article

References (15)

1. Athyros VG, Kakfika AI, Tziomalos K, Papageorgiou AA, Karagiannis A. Statins for the prevention of first or recurrent stroke. Curr Vasc Pharmacol 2008; 6: 124-133.
2. Nichols GA, Koro CE. Does statin therapy initiation increase the risk of myopathy? An observational study of 32, 225 diabetic and nondiabetic patients. Clin Ther 2007; 29: 1761-1770.
3. Thompson PD, Clarkson P, Karas RH. Statin associated myopathy. JAMA 2003; 289: 1681-1690.
4. Hamiliton-Craig I. Statin-associated myopathy. Med J Aust 2001; 175: 486-489.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA etal. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
6. Lee AJ, Maddix DS. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin [Review]. Ann Pharmacother 2001; 35: 26-31.
7. Roten L, Schoenenberger RA, Krahenbuhl S, Schlienger RG. Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother 2004; 38: 978-981.
8. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423.
9. Rowan C, Brinker AD, Nourjah P, Chang J, Mosholder A, Barrett JS etal. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. Pharmacoepidemiol Drug Saf 2009; 18: 301-309.
10. Stirling CM, Isles CG. Rhabdomyolysis due to simvastatin in a transplant patient: are some statins safer than others? Nephrol Dial Transplant 2001; 16: 873-874.
11. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011; 58: 1819-1824.
12. Aggarwal R, Lebiedz-Odrobina D, Sinha A, Manadan A, Case JP. Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies. J Rheumatol 2009; 36: 2711-2714.
13. Cox FM, Delgado V, Verschuuren JJ, Ballieux BE, Bax JJ, Wintzen AR etal. The heart in sporadic inclusion body myositis: a study in 51 patients. J Neurol 2010; 257: 447-451.
14. Sribhen K, Phankingthongkum R, Wannasilp N. Skeletal muscle disease as noncardiac cause of cardiac troponin T elevation [letter]. J Am Coll Cardiol 2012; 59: 1334-1335.
15. Hilmer S, Gnjidic D. Statins in older adults. Aust Prescr 2011; 34: 169-172.